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Abstract.  The clustering of acetylcholine receptors 
(AChR) in the postsynaptic membrane is an early 
event in the formation of the neuromuscular junction. 
The mechanism of clustering is still unknown, but is 
generally believed to be mediated by the postsynaptic 
cytoskeleton. We have identified an unusual isoform of 
B-spectrin which colocalizes with AChR in AChR 
clusters isolated from rat myotubes in vitro. A  related 
antigen is present postsynaptically at the neuromuscu- 
lar junction of the rat.  Immunoprecipitation, peptide 
mapping and immunofluorescence show that the 
/~-spectrin in AChR clusters resembles but is distinct 
from the B-spectrin of human erythrocytes, c~-Spectrin 
appears to be absent from AChR clusters.  Semiquan- 
titative immunofluorescence techniques indicate that 
there are from two to seven/~-spectrin molecules pres- 
ent for every clustered AChR, the higher values being 
otained from rapidly prepared clusters, the lower 
values from clusters that require several minutes or 
more for isolation.  Upon incubation of isolated AChR 
clusters for 1 h at room temperature, /3-spectrin is 
slowly depleted and the AChR redistribute into micro- 
aggregates. The/~-spectrin that remains associated 
with the myotube membrane is concentrated at these 
microaggregates. /3-Spectrin is quantitatively lost from 
clusters upon digestion with chymotrypsin, which 
causes AChR to redistribute in the plane of the mem- 
brane.  These results suggest that AChR in clusters is 
closely linked to an unusual isoform of/~-spectrin. 
T 
HE accumulation, or clustering, of acetylcholine re- 
ceptors  (AChR) t  in  the  postsynaptic  membrane  of 
embryonic skeletal muscle cells is one of  the first mor- 
phological changes  involved in the  formation of the ver- 
tebrate neuromuscular junction (e.g., references 2, 3, 8,  17, 
26, 29; see references 16, 65 for reviews). Although extracel- 
lular factors other than the motor neuron can influence the 
distribution of AChR in sarcolemma (reviewed in  16, 20, 
66),  cytoskeletal proteins appear to be most important in 
binding to and immobilizing receptors to form clusters (16, 
20,  31). Several  of these proteins have been  identified at 
AChR-rich membrane in vivo (15, 18, 30, 32, 36, 67, 68, 75) 
and in vitro (12-14,  19, 32, 47, 59). Actin is one such protein 
that is present postsynapticaUy (12, 36) and that appears to 
be involved in the formation or maintenance of AChR clus- 
ters in muscle cells in vitro (12, 27, 28, 47). 
Microfilaments underlie the AChR clusters of muscle cells 
cultured in vitro (58; Pumplin, D. W., manuscript submitted 
for publication; Bloch, R. J., M.  Velez,  J.  Krikorian, and 
D. Axelrod, manuscript submitted for publication), but it is 
not yet clear how these structures influence AChR clustering. 
1.  Abbreviations  used  in  this  paper:  AChR,  the nicotinic  acetylcholine 
receptor of skeletal muscle; FGAM, fluoresceinated goat anti-mouse IgG 
antibodies;  R-BT, monotetramethylrhodamine-~-bungarotoxin. 
At the AChR clusters of cultured rat myotubes, bundles of 
actin filaments are readily identified using fluorescent phal- 
loidin derivatives (Bloch, R. J., M. Velez, J. Krikorian, and 
D. Axelrod, manuscript submitted for publication), and by 
ultrastructural techniques (Pumplin, D. W., manuscript sub- 
mitted for publication). These microfilament bundles are not 
closely associated with the AChR-rich domains of these clus- 
ters, but are located over "contact domains" regions within 
the cluster that are poor in AChR and close to the tissue cul- 
ture substrate (Pumplin, D.  W., manuscript submitted for 
publication;  Bloch,  R.  J.,  M.  Velez,  J.  Krikorian,  and 
D. Axelrod, manuscript submitted for publication). These 
same regions are enriched in several  cytoskeletal proteins, 
including talin,  vinculin,  and ot-actinin  (14; Bloch R.  J., 
M. Velez, J. Krikorian, and D. Axelrod, manuscript submit- 
ted for publication), that are normally present where stress 
fibers terminate at the cell membrane (reviewed in 22, 33). 
All the cytoskeletal proteins underlying contact domains can 
be  removed from AChR clusters without disturbing their 
overall structure (11), suggesting that these proteins and the 
associated microfilamentous structures are not closely linked 
to clustered receptors. 
In addition to the large microfilamentous structures at con- 
tact domains of AChR clusters, actin also overlies "AChR 
domains," the regions within the cluster that are rich in re- 
ceptor (12). Ultrastructural studies reveal few microfilaments 
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publication). It has been suggested that actin at AChR do- 
mains may be present in a membrane-bound lattice resem- 
bling that of the human erythrocyte (12, 61). If this model is 
correct, then a protein resembling human erythrocyte spec- 
trin should be closely linked to AChR at AChR domains. The 
experiments presented in this paper support this prediction. 
We demonstrate that the clustered AChR of cultured rat 
myotubes are associated with an unusual isoform of the/3 
subunit of human erythrocyte spectrin. This isoform, which 
we refer to simply as B-spectrin, appears to be present at 
AChR clusters in significant amounts without a correspond- 
ing a-spectrin subunit.  /3-Spectrin  remains associated with 
the cluster membrane under conditions that remove actin, 
but is lost from clusters under conditions that do not remove 
the  AChR-associated  polypeptide,  43K  (or  v~;  references 
30,  35,  56).  AChR  and  /3-spectrin  appear  to  be  closely 
linked, however, as they redistribute together in the muscle 
membrane as  clusters are disrupted.  Our results  strongly 
suggest that an unusual isoform of/3-spectrin is bound, either 
directly or indirectly, to the AChR, and that this binding is 
important for the clustering of receptors. Based on our find- 
ings, we present a model of AChR clusters that postulates a 
complex of the AChR and the 43K protein bound to oligo- 
mers of ~-spectrin; these complexes may in turn be cross- 
linked by actin. 
Materials and Methods 
Cell Culture 
Rat myotubes were cultured on glass coverslips as described (9, 14). Briefly, 
cells were seeded onto coverslips and grown for 4  d  in  Dulbecco-Vogt 
modified Eagle's medium supplemented with  10%  FCS.  On day 4,  this 
medium was replaced with medium containing 20 #M cytosine arabinoside. 
Myotube cultures were used for experiments 2-4 d later.  For immunofluo- 
rescence experiments, cultures were usually labeled with monotetramethyl- 
rhodamine-a-bungarotoxin (R-BT; 62) before further processing. For im- 
munoprecipitation and peptide mapping, the medium added to cultures on 
day 4 was supplemented with [3SS]methionine  (0.1 mCi/ml). 
Isolation of  AChR Clusters 
For most experiments, we isolated AChR clusters by extracting myotube 
cultures with saponin, as described (11). Briefly, cultures were labeled with 
R-BT and extracted with a solution of 0.2% saponin in 10 mM NaP,  145 
mM NaCI,  pH 7.2  (PBS) supplemented with 10 mM MgCI2 and  1 mM 
EGTA. For immunofluorescence studies, we used method I of reference 11, 
which included 1 mg/ml BSA in the extraction buffer. For radiolabeling ex- 
periments, we used method II, which omitted serum albumin but added pro- 
tease inhibitors (11). Samples were rocked gently on a Luckham 802 suspen- 
sion mixer (Tekmar Co., Cincinnati, OH) for 5-10 rain, until the bulk of 
the cellular material was shed from the cover glass, usually for 5-10 rain. 
After extraction, cover glasses with attached AChR clusters were either ex- 
tracted with detergent, for immunoprecipitation, or fixed immediately, for 
immunofluorescence. For some immunofluorescence experiments, samples 
were transferred serially through two to four beakers containing PBS or 
buffer A (2 mM Tris-HCl, 0.2 mM ATP, pH 8.0; reference 73), incubated 
for 5-10 min at 22-24°C in 3 ml of these or different solutions, and then 
fixed. Fixation was with 2% paraformaldehyde in PBS for 15 rain. 
In some experiments, AChR clusters were isolated by the more rapid pro- 
cess of physical shearing (modified from 14). Briefly, cultures labeled with 
R-BT were incubated for 2 min at ambient temperature in a solution contain- 
ing Zn  ++ (1 mM ZnCI2,  3 mM EGTA, 5 mM MgC12, 100 mM Pipes, pH 
6.0; reference 4), and then sheared with a stream of ice cold "intracellular" 
buffer (100 mM KCI, 5 mM MgCI2, 3 mM EGTA, 20 mM Hepes, pH 7.0; 
reference 1).  In most cases,  samples were then immediately fixed with 
paraformaldehyde. Occasionally, however, sheared samples were washed by 
serial transfer and incubated further before fixation (see above). The proce- 
dure for shearing after treatment with ZnCI2 was adapted for use with rat 
myotubes by Dr. David W. Pumplin (Department of Anatomy, University 
of Maryland School of Medicine), who most generously made it available 
to us. 
lmmunofluorescence Labeling and Quantitation 
After fixation, samples were treated with 0.1 M glycine in PBS to inactivate 
any remaining aldehyde, and washed in PBS containing BSA at  1 mg/ml 
(PBS/BSA).  The latter solution was used for all dilutions and washing 
procedures described below.  Samples were inverted over 50 #1 droplets of 
antibody, incubated for 30 min at ambient temperature, washed three times, 
and labeled further with 50/d aliquots of fluoresceinated goat anti-mouse 
IgG (FGAM; Cappel Laboratories, Malvern, PA). 
For most of the experiments reported here, the anti-spectrin antibody 
used was VIIF7, a mouse monoclonal IgG1 specific for the/~ I region of hu- 
man erythrocyte spectrin (38). This was usually used at a 1:10 or 1:20 dilu- 
tion of partially purified antibody, obtained from ascites fluid by 50% am- 
monium sulfate precipitation and then reconstituted to its initial volume in 
PBS. In a few experiments, antibody purified by DEAE-cellulose chroma- 
tography was used at similar dilutions, equivalent to micromolar concentra- 
tions of total antibody. 
In one experiment, fixed samples were labeled with antibodies both to 
spectrin and to actin. These were not prelabeled with R-BT, but were other- 
wise treated as described above for cultures extracted with saponin. Antiac- 
tin (HP'249),  a mouse monoclonal IgM, was used at a dilution of ascites 
fluid of 1:40 (12).  It was visualized with FGAM (Litton Bionetics, Rock- 
ville, MD). The anti-/~-spectrin was produced in rabbits by injection and 
repeated boosting with purified human erythroeyte/~-spectrin, prepared as 
described (51, 72). The antibody was affinity purified by passing it over a 
column of cyanogen bromide-activated Sepharose 4B coupled to erythrocyte 
/~-spectrin, and eluting with 1 M acetic acid followed by dialysis into PBS. 
It was visualized using rhodaminylated goat anti-rabbit IgG (RGAR; Cap- 
pel Laboratories). Controls showed no species cross-reaction of the FGAM 
and RGAR. 
Quantitative  analysis of the  fluorescence signal  arising  from  AChR 
clusters was performed as described (12,  13). Briefly, the fluorescence aris- 
ing from a 5-#m circle of membrane was sampled through a pinhole aper- 
ture with a photomultiplier, and the signal was read by an I-to-V converter. 
After  correction  for  background  fluorescence, the  signal  arising  from 
FGAM (F) was divided by the signal arising from R-BT (R) bound to the 
same area of membrane. The ratio (F/R), usually varying by +10% (SEM) 
or less, was comparable from one sample to another. F/R did not change 
when we used higher concentrations of FGAM, indicating that this reagent 
was in excess. 
Immunoprecipitation and Peptide Mapping 
Cultures were metabolically  radiolabeled with [35S]methionine (see above). 
On day 7 of culture, clusters were isolated by extraction with saponin, fol- 
lowing method II of reference 11. The material isolated from 12 coverslips 
(25 nun diana) was extracted at room temperature with 0.05%  Triton X-100 
in TBS (50 mM Tris,  150 mM NaCI, pH 7.4).  AChR and #-spectrin are 
solubilized under these conditions  2. The detergent extract was lyophilized, 
redissolved in 500 #1 of precipitation buffer (5 mM EDTA,  10 mM Tris, 
0.02%  sodium azide, 30 #M PMSF, pH 7.6),  centrifuged at 30,000  g for 
5 rain to remove insoluble material, and incubated for 10 min at room tem- 
perature with 50 #1 of  a 10% suspension of washed and fixed Staphylococcal 
aureus cells (Pansorbin; Calbiochem-Behring Corp., San Diego, CA). Af- 
ter recentrifugation for 2 min, the cleared supernatant from this incubation 
was divided into two equal aliquots and incubated for 30 min at room tem- 
perature with 40 #1 of VIIF7 anti-/~-spectrin, or with a nonimmune serum. 
For these and all subsequent dilutions, NET buffer (150 mM NaCI, 50 mM 
Tris, 5 mM EDTA, 30 #M PMSF, 0.02 % sodium azide, pH 7.4) was used. 
Affinity-purified rabbit anti-mouse IgG antibody (20 #1; 0.7 mg/ml) was 
then  added  to  enhance  the  capture  of the  immune  complexes by  the 
Staphylococcal cells, and the incubation was continued for an additional 30 
rain. Finally, 25 #1 of fresh Staphylococcal cells were added to each sample 
and incubated for 20 rain. The samples were underlaid with 150 #1 of 1 M 
sucrose and centrifuged for 10 rain at 30,000 g at 4°C. The immunoprecipi- 
tates were solubilized at 90°C with sample buffer (42) and applied to SDS- 
PAGE,  performed according to Laemndi (42). 
2.  After solubilization under these conditions, AChR cochromatographs 
with monomeric AChR (•250  kD)  in gel filtration (Baetscher, M., and 
R. J. Bloch, unpublished data).  Detergent extraction therefore dissociates 
AChR from any cytoskeletal proteins with which it might interact in situ. 
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precipitated by VIIF7 or to human erythroeyte B-spectrin were excised from 
the gel and  labeled  with  12sI (Amersham  Corp., Arlington  Heights,  IL) 
using chloramine T (Sigma Chemical Co., St. Louis, MO), following previ- 
ously described procedures (72). Each gel slice was labeled with 1 mCi of 
~zsl. After the  iodination  reaction,  unbound  radioactive  iodine  was  re- 
moved by exhaustive washing with 10% methanol containing 5 izM tyrosine 
and 10 ~M KL The iodinated gel slices were digested at 37°C for 24 h with 
50 ~g of ~-chymotrypsin (Worthington Biochemical Corp., Freehold,  NIL 
in i  ml of 50 mM NI-tdHCOa, pH 8.0. The supernatant  was lyophilized, 
redissolved in 20 #1 of acetic acid/formic acid/water (15:5:80; [vol/vol/vol]) 
and  chromatographed  in  two  dimensions  using  Merck cellulose  sheets 
(Macalaster Bicknell Co., New Haven, CT). Other conditions were as de- 
scribed  (72). 
Frozen Sections 
Frozen  sections of rat diaphragm  were cut as described  previously  (15). 
Briefly, muscles were dissected and frozen in liquid hexane or isopentane, 
precooled  in  a dry  ice-acetone or dry  ice-methanol  bath.  Pieces  were 
trimmed, mounted on a brass block, and sectioned with a cryostat. Sections, 
4-tzm-thick, were picked up on glass slides, air dried, and stored in the pres- 
ence of dessicant at  -70°C. Sections nf denervated diaphragm.were  pre- 
pared  from phrenectomized  rats,  provided by Zivic-Miller Laboratories, 
lnc. (Allison Park,  PA). 
Microscopy and Photomicrography 
Samples observed by fluorescence microscopy were mounted in a solution 
consisting of nine parts glycerol,  one part  1.0 M Tris-HC1, pH 8.0, sup- 
plemented  with  1 mg/ml p-phenylenediamine,  to reduce  photobleaching 
(39). Fluorescence observations were made on a Zeiss IM35 microscope 
equipped  for epifluorescence, with one of two Zeiss Plan Neofluar objec- 
tives: NA, 0.8; and NA, 1.25. Photography employed Ilford HP-5 film (ASA 
400; Ilford Ltd., Basildon, Essex, England) processed to an ASA of "~3,200 
with Ilford Microphen developer. Exposure times varied from  10 1o 60 s, 
Figure L  B-Spectrin at isolated AChR clusters.  Rat myotubes were labeled with R-BI' and either extracted with saponin  (E--H; method 
I of reference 11) or treated briefly with ZnCI2 and then sheared (A-D). Samples were immediately fixed in paraformaldehyde and labeled 
with VHF7 anti-B-spectdn followed by FGAM. A, C, E, and G show R-BT fluorescence; B, D, F,, and H show B-spectrin immunofluores- 
cence. (,4 and B) Sheared sample at low magnification showing anti-B-spectrin labeling at AChR clusters (arrowheads) and in filamentous 
structures of both myotubes and fibroblasts (double arrowheads). (C and D) Sheared sample at higher magnification showing that VIIF7 
labels AChR domains (arrowheads), but not contact domains (double arrowheads). (E and F) Sample isolated with saponin at low mag- 
nification, showing that the only sites of enrichment of VIIF7 labeling eoineide with AChR clusters (arrowheads). (G and H) Sample iso- 
lated with saponin, at higher magnification, showing that VI~7 labels AChR domains (arrowheads), but not contact domains (double ar- 
rowheads). The asterisks (C,/9,  G, and H) indicate limited areas that label brightly for AChR but only slightly for B-spectrin. Bars: (F) 
25 t~m;  (H)  10 t~m. 
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Our aim in the experiments presented here was to determine 
if spectrin is associated with clustered AChR in cultured rat 
myotubes, and, if so, to characterize this association further. 
In our preliminary experiments, we therefore screened a li- 
brary of monoclonal and polyclonal antibodies against eryth- 
rocyte spectrin and brain spectrin (fodrin) to learn if they 
bound to AChR clusters. In this, as in later experiments, all 
immunolocalization of spectrin was performed using fluo- 
rescence techniques. High levels of generalized cytoplasmic 
fluorescence in detergent-permeabilized myotubes made it 
difficult to study spectrin at the AChR clusters of whole cells. 
We therefore used two different methods to remove the bulk 
of the cytoplasm and expose the intracellular surfaces of the 
clusters to antibody.  Both rely on the fact that the AChR 
clusters of cultured rat myotubes are localized at  sites  of 
membrane-substrate attachment (5,  14, 43), and are left be- 
hind on the cover glass when the bulk of the muscle cell is 
removed. The first technique, shearing the myotube cultures 
with a stream of buffer (14), yields AChR clusters together 
with associated cytoplasmic structures, such as stress fibers 
and coated vesicles (Pumplin, D. W., manuscript submitted 
for publication), as well as fragments of contaminating fibro- 
blasts.  The second method, extraction for 5-10 min with a 
buffered solution of saponin, yields AChR clusters purified 
~100-fold, still contaminated with substrate-attached mem- 
brane from fibroblasts, but essentially free of contamination 
from cytoplasmic structures (11). 
Spectrin at AChR Clusters 
When we exposed AChR clusters prepared by shearing or by 
extraction with saponin to a battery of anti-spectrin antibod- 
ies,  we  obtained  significant  labeling  with  two:  VIIFT,  a 
mouse monoclonal antibody specific for the/3 I domain of 
human erythrocyte/~-spectrin (reference 38; see Fig. 1), and 
an affinity-purified preparation of one rabbit anti-B-spectrin 
(see Fig. 9). VIIF7 also labels filamentous structures in frag- 
ments of myotubes and fibroblasts that remain after shearing 
(Fig.  1, A and B). Upon closer examination of AChR clus- 
ters,  we  found that  VIIF7  labeled  the  AChR  domains  of 
clusters,  but not the contact domains,  which are poor in 
AChR (Fig.  1, C and D). Similarly, ~-spectrin was not en- 
riched at the focal contacts of  fibroblasts (not shown), consis- 
tent with reports that the latter are devoid of spectrin (23). 
These observations suggested that a  spectrin-like molecule 
is present in the AChR domains of AChR clusters,  and in 
filamentous structures in both myotubes and fibroblasts. 
In contrast to samples prepared by shearing, myotube cul- 
tures extracted with saponin show very little spectrin-like 
material in  fibroblast fragments and in areas  of myotubes 
lacking clusters  (Fig.  1,  E  and F).  Observation at higher 
magnification (Fig.  1,  G and H) confirmed that VIIF7 la- 
beled the AChR domains (arrowheads) and not the contact 
domains (double arrowheads) of AChR clusters. 
Although the correlation between the distribution of  AChR 
and fl-spectrin in isolated clusters was strong, we did find 
limited regions of some clusters, prepared either by shearing 
or by extraction with saponin, that lacked significant amounts 
of/$-spectrin (Fig.  1, C, D, G, and H, asterisks). The AChR 
in these areas was often stained to a lesser extent with R-BT 
and was less well-organized than receptors in other parts of 
the cluster, suggesting that these areas were in the process 
of accumulating or losing AChR (see Discussion). Whatever 
causes the occasional absence of immunolabeling, our re- 
sults clearly establish that the spectrin-like material obtained 
after extraction with saponin is highly enriched at the AChR 
domains of clusters, and is not present in significant amounts 
in any other structures.  We therefore used the saponin-ex- 
tracted preparation to study the cluster-associated spectrin 
further. 
We characterized the/3-spectrin-like molecule associated 
with  AChR  clusters  further  by  immunoprecipitation  and 
peptide  mapping.  Immunoprecipitation  of material  from 
receptor cluster preparations which had been metabolically 
radiolabeled with  [~sS]methionine  showed that a  polypep- 
tide with an apparent mass of 220,000 D  reacted with the 
VIIF7 anti-B-spectrin (Fig.  2).  No other polypeptide was 
specifically precipitated by the antibody.  Thus the immu- 
nofluorescence labeling obtained with anti-/3-spectrin was 
due to the presence at AChR domains of a molecule of the 
same apparent polypeptide chain molecular weight as human 
erythrocyte B-spectrin (Mr  =  220,000;  Fig.  2 A).  Signifi- 
cantly, even under the low stringency conditions for immu- 
noprecipitation employed here, no peptide corresponding to 
tx-spectrin (240,000-Mr)  was precipitated, 
We prepared two-dimensional cellulose ~25I-peptide maps 
Figure 2.  A  high  molecular 
mass peptide is specifically  im- 
munoprecipitated  by the VI1F7 
anti-B-spectrin. Rat myotubes 
were  grown  on  large  glass 
coverslips and extracted with 
saponin, following method II 
of  reference 11, except that the 
medium added on day 4 of cul- 
ture  was  supplemented with 
0.1  mCi  of [35S]methionine. 
On day 7,  clusters were iso- 
lated after extraction with sa- 
ponin.  The material isolated 
from  12  coverslips (25  mm 
diam) was extracted with Tri- 
ton X-100 and the extract was 
subjected to  immunoprecipi- 
tation by VIIF7 (see Materials 
and Methods). The immuno- 
precipitates were analyzed by SDS-PAGE. (Lane a)  Coomassie 
Blue-stained gel of human erythrocyte ghosts containing BSA and 
cytochrome C as molecular mass standards. The ~ and ~ subunits 
of human erythrocyte spectrin are marked (240,000 and 220,000 
Mr,  respectively). The two arrows indicate the position of BSA 
and actin (68,000 and 43,000 Mr, respectively). (Lanes b-d) Au- 
toradiograms of the immunoprecipitates of the samples that had 
been  metabolically radiolabeled with  [3SS]methionine. (Lane b) 
Precipitation by VIIF7 anti-/~-spectrin, showing a high molecular 
mass polypeptide which  migrates near the position of the beta 
subunit of erythrocyte spectrin. (Lane c) Precipitation by nonim- 
mune rabbit serum, used as a control.  No high molecular mass 
peptide  is  evident.  A  mouse monoclonal antibody that  reacted 
specifically with rat brain synapsin I also failed to precipitate the 
high molecular mass polypeptide (not shown). (Lane d) Material 
precipitated by the Streptococcal cells alone, during the prewashing 
procedure. Only the VIIF7 anti-/~-spectrin precipitates a high mo- 
lecular mass polypeptide. 
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pare it with other spectrin isoforms. Our results (Fig. 3) indi- 
cate that the cluster-associated polypeptide is  similar,  but 
not identical to the B subunit of human erthrocyte spectrin: 
39  of the 48  discrete spots  (81%)  on the  map  of muscle 
B-spectrin correspond closely to those for human erythro- 
cyte ~-spectrin.  Similar comparison of muscle ~-spectrin 
with the 235-kD  fl subunit of brain  spectrin (37)  showed 
significantly less homology (not shown). The peptide maps 
are therefore consistent with the idea that preparations of 
AChR clusters from rat myotubes contain a form of B-spec- 
trin that is similar but not identical to the •  subunit of human 
erythrocyte spectrin. For brevity, we refer to this molecule 
simply as B-spectrin. 
As mentioned above, several other polyclonal and mono- 
clonal antibodies to human erythrocyte and pig brain spec- 
trins failed to label AChR clusters (Table I). We examined 
the monoclonal antibodies on this list further, m determine 
if they reacted in immunoblots of spectrin from rat erythro- 
cytes. We also tested their ability to react with spectrin still 
bound to human erythrocyte membranes (Ursitti, J. A., and 
R. J. Bloch, unpublished results). Most were active by both 
criteria; the sole exception was mAb VIIIC7, which bound 
to rat erythroid/~-spectrin in immunoblots but did not label 
membrane-bound spectrin. Thus, these antibodies were ac- 
tive and (with the exception of VIIIC7) able to bind to mem- 
brane-associated spectrin. These results support the conclu- 
sion,  reached from peptide  mapping,  that  the  isoform of 
/~-spectrin  at  AChR clusters is  similar,  but distinct from, 
~erythroid spectrin, and that it is not associated with an 
subunit. 
Semiquantitative Measurements 
We next measured,  semiquantitatively, how much spectrin 
was associated with AChR in clusters. To do so, we deter- 
mined the intensity of the fluorescein fluorescence due to 
VIIF7 and FGAM binding and compared this to the intensity 
of R-BT fluorescence from the same patch of membrane (12, 
13).  The amount of fluoresceinated antibody bound varied 
linearly with the amount of  R-BT (Fig. 4, inset). Thus, at any 
given concentration of antibody, the ratio of fluorescein (F) 
to rhodamine (R) fluorescence was constant. By varying the 
concentration of  VIIF7, we obtained a binding isotherm (Fig. 
4) that saturated at a F/R ratio of 2.0 (mean in four experi- 
Figure 3. The protein precipitated by VIIF7 has a peptide map simi- 
lar to that for erythrocyte/3-spectrin. The gel bands corresponding 
to the high molecular mass peptide immunoprecipitated by VIIF7 
(b) or to human erythrocyte B-speetrin were excised and labeled 
with '2~I using chloramine T, extensively digested with u-ebymo- 
trypsin,  and chromatographed in two dimensions (see Materials 
and Methods). (a) Autoradiogram  showing  the map of the 220,000-D 
polypeptide specifically immtmoprecipitated by VI1FT. (b) Map of 
erythrocyte #-spectrin.  (c) Cartoon depicting the features of the 
maps shown in a and b. Shared spots are solid. Peptides present in 
the myotube fl-spectrin but absent in erythroeyte B-spectrin are 
open. Peptides present in erythrocyte/3-spectdn  but absent in the 
myotube B-spectrin are dotted. Overall, 81% (39 of  48) of the spots 
in the map of myotube fl-spectrin correspond with spots in the map 
of erythrocyte B-spectrin. 
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AChR Clusters 
Immunofluorescence 
Antibody  Specificity  of AChR Clusters 
Monoclonals 
VIIF'/  Spectrin,  /$ I domain  Bright 
IVF8  Spectrin,  ~ I domain  Poor 
VD4  Spectrin,  /~ IV domain  Poor 
VIIIC7  Spectrin,  ~ II domain  Poor 
IID2  Spectrin,  a  I domain  Poor 
Polyclonals 
Anti-~  Spectrin  beta chain  Bright 
RAS C  Spectrin  alpha chain  Poor 
RAF A  Fodrin  Poor 
Rat myotubes were labeled with R-BT, extracted with saponin, fixed, and la- 
beled with one of a panel of antibodies to erythrocyte speetrin and brain fodrin. 
Only  VIIF7  and a polyclonal  antiserum  to human erythrocyte  beta  spectrin 
labeled clusters.  The specificities of the monoclonal antibodies are described 
in references  38 and 77. 
ments, 2.35  +  0.55 SEM).  Using purified VIIF7, we found 
that the concentration of antibody needed to reach half-max- 
imal  saturation  was  ,,ol  #M  (not  shown),  suggesting  that 
VIIF7 has  rather  low  affinity  for the/~-spectrin  at AChR 
clusters. 
When we studied the spectrin at AChR clusters prepared 
by shearing, we obtained somewhat different results. The im- 
munofluorescence  ratio,  F/R,  at near-saturating  concentra- 
tions of VIIF7 was 4.9  +  0.58 (mean +  SEM n  =  5; range 
3.5 to 6.5), significantly greater (p <  0.05 by t test) than that 
obtained  with  AChR  clusters  isolated  by  extraction  with 
saponin from parallel cultures. Clusters isolated by shearing 
are prepared and fixed in <15 s; those isolated by extraction 
with saponin require 5-10 min of incubation before fixation. 
We therefore investigated the possibility that/~-spectrin was 
lost from clusters during longer incubations. The data in Fig. 
5  show  that this  is  indeed  the  case.  Clusters  prepared  by 
1.5 
1.0 
0.5 
.2  .4 
4  8  12 
VIIF7  (ul) 
Figure  4.  Semiquantitative 
analysis of VIIF7 anti-B-spec- 
trin binding to isolated AChR 
clusters. Cultures of rat myo- 
tubes were labeled with R-BT, 
extracted  with  saponin,  and 
immediately  fixed.  Samples 
were  stained  with  different 
amounts of VHF7, diluted from 
ascites fluid into PBS/BSA to 
a final volume of 50 #1. Sam- 
ples were washed and  coun- 
terstained with FGAM as in Fig. 1. Fluorescein (F) and rhodamine 
(R) fluorescence arising  from 5-#m diam regions within AChR 
clusters  were measured using  a  photomultiplier  attached  to the 
fluorescence microscope. The results were plotted as a function of 
the amount of VIIF7 (points are means  +  SEM;  n,  9-12).  The 
curve is a rectangular hyperbola with F/R~x =  2.0 and [VIIF7]I/2 
=  3.2. In experiments using purified VHF7, half-maximal labeling 
was obtained with ,'-1 #M VIIF7. (Inset) Fluorescein fluorescence 
(F) plotted as a function of the rhodamine fluorescence (R) from 
a sample labeled with saturating amounts of VIIF7. Points within 
clusters (+) and background values (m) are shown. The solid line, 
generated by linear regression analysis (r  =  0.891),  has a  slope 
of 1.95. 
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Figure 5.  Spectrin  is depleted 
from clusters incubated in buff- 
ered  saline.  Rat  myotube cul- 
tures  were  labeled  with  R-BT 
and clusters were isolated either 
by shearing  (o)  or by extrac- 
tion with saponin (zx), washed 
twice  by  serial  transfer,  and 
then  incubated  in  buffered sa- 
line for different periods of time. Samples were fixed and labeled 
with VIIF7 and FGAM. The F/R ratios were determined as in Fig. 
4. The solid circle indicates nonspecific labeling, which was very 
low for samples prepared by either method. The results show that 
labeling by VIIF7 declines upon incubation of isolated AChR clus- 
ters. Values are means  +  SEM (n  =  10).  Symbols lacking error 
bars represent values for which the SEM was too small. 
shearing and immediately fixed gave F/R ratios significantly 
greater (p < 0.05) than those that were sheared and incubated 
for 5  min in PBS or in the presence of saponin.  The latter 
gave values  that were  not  significantly  different  (p  >  0.8) 
from those obtained with AChR clusters isolated using sapo- 
nin alone. These results suggest that some of the ~-spectrin 
at AChR clusters is only loosely associated with the myotube 
membrane. 
We subjected AChR clusters to several different treatments 
to learn if we could deplete more of the spectrin from AChR 
clusters, and if this could be correlated with changes in the 
organization  of AChR  in  the  membrane.  Treatment  with 
buffer A  (2 mM Tris-HCl, 0.2 mM ATE pH 8.0; reference 
73)  did  not  cause  further  loss  of spectrin  from  saponin- 
isolated  AChR  clusters.  Extraction  at pH  11  or  treatment 
with chymotrypsin eliminated nearly all specific labeling by 
VIIF7,  however  (Fig.  6  A).  Similarly,  VIIF7  labeling  of 
sheared AChR clusters was drastically reduced by digestion 
with chymotrypsin, but not by extraction with buffer A (Fig. 
6B). 
The fluorescence images of clusters treated with buffer A 
or chymotrypsin are shown in Fig.  7.  As expected (12;  see 
above),  these  samples  showed  significant  changes  in both 
AChR and/$-spectrin (Fig. 7, C-F). Receptors in both sam- 
ples were more evenly distributed in the plane of the mem- 
brane, with little evidence of the membrane domains seen in 
controls./~-spectrin labeling was still bright in clusters treat- 
ed with buffer A, but,  like AChR,  was redistributed  across 
the membrane plaque (Fig. 7 D). Microaggregation of AChR 
was often observed in the samples treated with chymotrypsin 
(Fig.  7  E).  In agreement with the semiquantitative  data in 
PBS  A  Ct  pHII  PBS  A  Ct 
Figure 6.  Spectrin in clusters 
subjected  to different extrac- 
tions.  (A) Myotubes were la- 
beled, extracted with saponin, 
washed twice in either buffer 
A  (that  sample,  only)  or  in 
buffered  saline  (all  others), 
and then incubated for 5 min 
at room temperature in 3 ml of 
buffered saline (PBS), buffer A (A), buffered saline supplemented 
with  10 #g/ml chymotrypsin (Ct), or 50 mM ethanolamine-HC1, 
pH 11  (pH 1/). After extraction, all samples were then fixed and 
labeled with VIIF7 and FGAM, and quantitated as in the legend to 
Fig. 4. (B) AChR clusters isolated by shearing and then treated in 
PBS,  buffer A, or chymotrypsin, as in A. 
The Journal of Cell Biology, Volume  108, 1989  486 Figure 7./3-Spectrin is lost upon treatment with chymotrypsin, but not upon extraction at low ionic strength. AChR clusters were labeled 
with  R-BT and  isolated from rat myotubes by extraction  with  saponin.  Samples were then treated  with buffered saline,  buffer A, or 
chymotrypsin,  as described  in Fig. 6, labeled with VHF7 and FGAM,  and photographed under fluorescence illumination.  A, C, and E 
show AChR, visualized with R-BT; B, D, and F show/3-spectrin,  visualized with VIIF7 and FGAM.  (,4 and B) Control cluster, washed 
and incubated in PBS, showing codistribution of AChR and 13-spectrin in AChR domains (arrowheads),  but not in contact domains (double 
arrowheads). (Cand D) Cluster washed and incubated in buffer A, which removes actin from the clusters (12), showing a more even distribu- 
tion of AChR and B-spectrin. 15-Spectrin is retained after extraction with buffer A. (E and F) Cluster washed in PBS and incubated in 
PBS plus chymotrypsin,  showing a redistribution of AChR, with some microaggregation (E, arrowhead)./3-Spectrin  is lost upon exposure 
to chymotrypsin.  Bar,  10 tzm. 
Fig. 6, ~spectrin was almost completely absent from these 
samples (Fig. 7 F). This effect of chymotrypsin was not ob- 
served if the enzyme was first inactivated with PMSF or by 
boiling  (not  shown).  SDS-PAGE  of samples  treated  with 
buffer A or with chymotrypsin were consistent with our im- 
munofluorescence results.  Control  samples contained  sev- 
eral bands with high apparent polypeptide chain molecular 
masses (200-250  kD),  including  a  band near 220,000 Mr. 
These high molecular mass bands were unaffected by extrac- 
tion  with buffer A,  but  were all  lost from chymotrypsin- 
treated samples, together with several other smaller polypep- 
tides (not shown). The apparently rapid proteolytic degrada- 
tion of/3-spectrin observed here has also been observed in 
in vitro studies  (71).  These results are consistent with the 
idea that buffer A causes both AChR and/~-spectrin to redis- 
tribute  in  the  muscle membrane,  and  that proteolysis de- 
stroys fl-spectrin and disrupts AChR organization. 
Coaggregation of  /3-Spectrin and AChR 
The  experiments  described  above  suggest  that  /3-spectrin 
may redistribute with AChR in clusters treated with buffer 
A. We sought more definitive evidence that the distribution 
of these  two proteins  was  closely  linked,  and  so  studied 
AChR clusters that were severely disorganized. 
AChR  clusters  can  be  dispersed  in  intact  myotubes by 
treatment with azide (9) or by withdrawing  Ca  2÷ from the 
culture  medium (10, 24).  We exposed cells to  both treat- 
ments,  and then  extracted  them with  saponin and  labeled 
Bloch and Morrow Spectrin  at Acetylcholine  Receptor Clusters  487 Figure & B-Spectrin at dispersing  or reforming AChR clusters.  Rat myotube cultures  were labeled  with R-BT with or without treatment 
to disrupt AChR clusters.  Clusters  were isolated by shearing  (I and J) or by extraction  with saponin,  and either fixed immediately  (A-F) 
or incubated  for 1 h in buffered  saline before fixation (G-J). All samples  were then labeled  with VIIF7 and FGAM. A, C, E, G, and I 
show R-BT label; B, D, F, H, and J  show immunofluorescence of/~-spectrin.  (A and B) Sample treated  for 4 h with 5 mM sodium azide, 
to disrupt AChR clusters.  (C and D) Sample treated  for 4 h in medium depleted  of Ca  2÷, to disrupt AChR clusters.  (E and F) Sample 
incubated for 6 h in azide, and then washed and incubated for 2.5 h in control medium, to allow AChR clusters to start to reform. Controls 
for the experiments  in A-F showed that, after 6 h of treatment  in azide or in medium lacking  Ca  2+, >90% of the AChR clusters  present 
at the beginning  of the treatment were dispersed.  (G and H) Sample extracted  with saponin and incubated  for 1 h before fixation.  (I and 
J) Sample prepared by shearing and incubated  for 1 h before fixation.  The results  indicate that B-spectrin is associated  with AChR even 
in highly disrupted  clusters.  Bar,  10 #m. 
them with VIIF7 and FGAM. The results (Fig. 8, A-D) show 
that, like actin (12), B-spectrin is lost from cluster membrane 
more or less in parallel  with AChR: areas  of clusters  that 
have lost AChR are also poor in/~-spectrin,  whereas areas 
that still  retain AChR also retain/~-spectrin.  In related  ex- 
periments,  we examined cells several hours after removal of 
azide,  when AChR clusters  reform (9).  ~Spectrin was as- 
sociated with all reforming AChR clusters in these samples 
(Fig.  8,  E  and  F).  The  F/R  ratios  for VIIF7 labeling  of 
/~-spectrin in reforming AChR clusters  and in clusters dis- 
The Journal of Cell Biology, Volume  108, 1989  488 Figure 9. Spectrin codistributes with actin within isolated receptor 
clusters. Rat myotube  cultures were subjected  to saponin extraction, 
and immediately fixed in paraformaldehyde.  Samples were labeled 
with a monoclonal antibody to actin (HP249; reference 12) and 
FGAM (A) and, simultaneously,  with an affinity-purified  rabbit an- 
tibody to/~-erythroid spectrin and RGAR (B). Actin and spectrin 
codistribute. Bar, 10 #m. 
rupted by azide or Ca  2÷ depletion are  similar to those of 
control clusters (F/R =  2.5--4.0 in treated samples and con- 
trois). This suggests that/3-spectrin is not lost from or added 
to clusters independently of AChR. 
We investigated the linkage between AChR and/~-spectrin 
further by studying clusters that reorganize spontaneously. 
AChR clusters that are isolated either by shearing or by ex- 
traction with saponin and then incubated for 1 h in buffered 
saline lose a significant portion of their/3-spectrin (Fig. 5). 
They  also  fail to  display the AChR-rich  and  AChR-poor 
membrane domains typical of freshly isolated structures. In- 
stead, the receptors in these clusters redistribute into irregu- 
larly spaced  microaggregates.  Most  of the  /3-spectrin  re- 
maining in the reorganized clusters is enriched at the AChR 
microaggregates (Fig. 8, G--J). Thus, ~-spectrin and AChR 
remain associated even under conditions in which/~-spectrin 
is  slowly lost from cluster membrane and the  AChR re- 
distribute in the bilayer. These results strongly suggest that 
/3-spectrin  and AChR are closely associated. 
Codistribution with Actin 
Actin has been shown to be present at the AChR domains, 
but not the contact domains, of AChR clusters isolated by ex- 
traction with saponin (12). We performed double immuno- 
fluorescence labeling experiments using a mouse monoclo- 
nal antiactin (12) and an affinity-purified rabbit antibody to 
~-spectrin to learn if/~-spectrin and actin codistribute. Con- 
trois showed that all the labeling we observed was specific 
for the antigen probed  (see Materials and Methods).  Our 
results showed that/3-spectrin codistributes with actin (Fig. 
9).  Comparison with samples labeled with R-BT and anti- 
bodies to/~-spectrin, actin, or the 43K protein, showed that 
the types of labeling depicted in Fig. 9 were only obtained 
at AChR clusters. 
The Neuromuscular Junction 
We labeled frozen sections through the junctional region of 
rat diaphragm muscle to determine if ~-spectrin is present 
there.  Junctional  regions,  identified using  R-BT,  labeled 
brightly with VIIF7 and FGAM (Fig.  10, A and B, arrow- 
heads), suggesting that/~-spectrin is indeed a synaptic anti- 
gen. We also examined frozen sections of muscles that had 
been denervated for "o14 wk, and found bright labeling for 
/3-spectrin at former endplate regions (Fig. 10, C and D, ar- 
rowheads). Extrajunctional regions were also labeled in both 
control and denervated muscles (double arrowheads).  La- 
beling of  junctional and extrajunctional regions by a control 
mouse IgG (mope 21) was insignificant (Fig.  10, E and F). 
These results suggest that/3-spectrin is a junctional antigen, 
and, because presynaptic structures are lost from muscle 
denervated for more than 5 wk (49),  is present in the post- 
synaptic region. 
Discussion 
Using the criteria of  immunofluorescence, immunoprecipita- 
tion, and peptide mapping, we have found a protein in prepa- 
rations of isolated AChR clusters that appears to be a new 
isoform of/~-spectrin. Although its polypeptide chain molec- 
ular mass, 220,000D  is similar to that of human erythroid 
~-spectrin, the ~-spectrin at AChR clusters has a different 
peptide map. This is probably not due to species differences 
alone, as maps of  rat erythroid ~-spectrin show several major 
spots that are not present in ~-spectrin from AChR clusters 
(W. Knowles, personal communication). The ~-spectrin at 
AChR clusters is also immun01ogically distinct, as it fails to 
bind several  monoclonal antibodies that react with the rat 
erythroid isoform in immunoblots. Its mass further distin- 
guishes the ~-spectrin we have studied from the common 
/3-spectrin  isoforms of brain  and other  tissues,  including 
skeletal muscle,  which  are  larger  (Mr  =  235,000;  refer- 
ences 37, 44, 53, 63, 70). Thus the/~-spectrin at AChR clus- 
ters resembles, but is distinct from, ~-spectrin isoforms from 
brain and erythrocytes. 
Another feature that distinguishes the/3-spectrin at AChR 
clusters from other ~-spectrins is the apparent absence of an 
associated ~ chain. In nearly all the cells where it has been 
found, spectrin is an heterodimer composed of ot and ~ sub- 
units which can be distinguished on the basis of their bio- 
chemical and antigenic properties (see references 7 and 48, 
and references therein). We have been unable to identify a 
second spectrin subunit resembling erythroid ot-spectrin  in 
preparations of isolated AChR clusters. A set of monoclonal 
and polyclonal, affinity-purified antibodies directed against 
the c~ subunits of human erythrocyte or human or pig brain 
spectrins failed to label AChR clusters. If/~-spectrin in clus- 
ters exists as an heterodimer, its paired subunit, therefore, 
Bloch and Morrow Spectrin  at Acetylcholine  Receptor Clusters  489 Figure 10. #-Spectrin at the neuromuscular junction. Frozen sections, 4 t~m thick, were cut through the junctional regions of diaphragms 
from control rats (A, B, E, and F), or from rats that had been phrenectomized 14 wk earlier (C and D). Sections were labeled, unfixed, 
with VIIF7 and FGAM, and with R-BT, to reveal the junctional regions (A-D). Additional sections were labeled with mope 21, a control 
mouse IgG (E and F). A, C, and E show R-BT fluorescence; B, D, and F show immunofluorescence. The results indicate that, in the rat, 
/3-spectrin is present in the postsynaptic region of the neuromuscular junction (A-D, arrowheads). Immunofluorescence due to/5-spectrin 
was also apparent in extrajunctional regions (B and D, double arrowheads). Bar, 20 t~m. 
may be a unique isoform. Different isoforms of spectrin have 
been extensively studied in avian cells (e.g., references 44, 
45, 53, 54, 57) and mammalian isoforms have been reported 
in human skeletal muscle (70), mouse brain (63), rat Sertoli 
cells (80), and in Friend erythroleukemia  cells (34). Alterna- 
tively, the/3-spectrin associated with clusters may be present 
as  homotetramers,  reported to  exist  in  chicken erythroid 
cells and to bind to the cytoplasmic face of erythrocyte  mem- 
branes with low affinity (76). 
Our experiments showing that AChR and/3-spectrin redis- 
tribute together in cluster membrane suggest that these two 
proteins are closely linked. Of the proteins present at AChR 
clusters, only the 43K protein appears to be more closely as- 
sociated with the AChR in situ (e.g., references 21, 56, 69). 
In the AChR clusters of rat myotubes, the 43K protein is ap- 
proximately equimolar with AChR, and can only be removed 
from clusters by extraction at pH  11  or with lithium diio- 
dosalicylate (13). It is not removed from clusters by chymo- 
trypsin (13), which does, however, remove #-spectrin. Actin, 
on the other hand, is depleted from isolated AChR clusters by 
buffer A (12), which does not affect B-spectrin. Other cyto- 
skeletal proteins of clusters, present over AChR-poor domains 
(14; Bloch, R. J,, M. Velez, J. Krikorian, and D. Axelrod, 
manuscript submitted for publication), are removed almost 
quantitatively by extraction with saponln without disrupting 
cluster organization (11), and so are not directly associated 
with AChR. Thus, of  the proteins we have studied, ~-spectrin 
appears to be more readily dissociated from AChR than the 
43K protein, but less readily dissociated than actin and some 
other cytoskeletal proteins. 
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Figure 11. Hypothetical model of 
the  membrane  skeleton  of the 
AChR domain. Oligomeric actin 
cross-links/~-spectrin, organized 
as tetramers or oligomers. This 
network is anchored to the mem- 
brane  bilayer  through  the  43K 
protein, which in turn is bound to 
the AChR. This model accounts 
for all of  the proteins so far identi- 
fied at the AChR domains of the 
AChR clusters of rat myotubes, the relative ease of extracting these proteins from the AChR domains, and the relative amounts of AChR, 
43K, and/$-spectrin estimated to be present. Higher oligomers of/~-spectrin (hemmers, octamers) are not shown, but may be present. 
Evidence for the binding of the 43K protein to spectrin and the oligomeric nature of the actin is still lacking. Not drawn to scale. 
The possibility that structural proteins at AChR domains 
are highly ordered prompted us to quantitate the amount of 
/3-spectrin at clusters relative to AChR. This approach was 
made possible by the fact that VIIF7  is  an IgG~. Earlier 
semiquantitative work on AChR clusters with IgG,  mAbs 
against AChR and the 43K protein yielded fluorescein anti- 
body/R-BT (F/R) ratios of'~l for both antibodies, consistent 
with a stoichiometry of their respective antigens of 1:1 (13). 
If one assumes that FGAM reacts equally well with all IgG~ 
monoclonal antibodies, and that the number of ligand bind- 
ing sites of  the mAb that are occupied by the antigen is always 
either one or two, then the value of F/R obtained with VIIF7 
should provide an estimate of the relative stoichiometry of 
~-spectrin and AChR at AChR clusters. Preliminary results 
in quantitative ELISA experiments suggest that the former 
assumption is correct (Resneck, W. G., and R. J. Bloch, un- 
published data). If the latter assumption is wrong, then we 
may have to modify our estimate, but only by a factor of two. 
This twofold uncertainty does not concern us at present, as 
the range of the F/R ratios we have obtained using VIIF7 is 
of the same magnitude. The interpretation of our results is 
further complicated by the evidence that/$-spectrin is lost 
from AChR clusters upon incubation. Nevertheless, sheared 
AChR clusters, which should lose the least amount of  antigen 
during their preparation, yield F/R values of 3.5-6.5. Thus, 
we propose that AChR clusters contain four to seven/3-spec- 
trin moieties for each molecule of AChR and 43K protein. 
The simplest organization of these molecules that would 
be consistent with their stoichiometries and their relative 
ease of  extraction from clusters is depicted in Fig. 11. A simi- 
lar organization is found in the human erythrocyte, where 
spectfin, present largely as tetramers with some higher oligo- 
mers (6, 46, 50, 52), is bound to the membrane largely through 
interactions with ankyrin (for reviews, see references 7, 48). 
We propose that spectfin at AChR clusters is linked to AChR 
by the receptor-associated 43K protein. The model shown in 
Fig. 11 does not include interactions between the 43K protein 
and actin (74), or other postsynaptic proteins, such as the 
58K and 300K proteins (32, 75). It may, therefore, have to 
be revised or discarded as we learn more about these proteins 
and their association with clustered AChR. 
The presence of several /~-spectrin molecules  for each 
AChR and 43K protein may help to account for the loss of 
spectrin from clusters after their isolation.  The shedding 
of/3-spectrin could be due to gradual depolymerization of 
oligomeric and tetrameric/$-spectdn to dimers and mono- 
mers, leaving bound to the membrane only those subunits 
that are closely associated with AChR. Spectrin depolymer- 
ization, reported to occur after solubilization of the human 
erythrocyte  membrane (46), would be consistent with the ap- 
parent stoichiometry, deduced from the F/R ratios, of one 
/~-spectrin homodimer for each AChR present in  isolated 
clusters after long incubations (Fig. 5). 
Our observation that some regions of clusters are not en- 
riched in /3-spectrin (Fig.  1,  C  and  D,  asterisks)  may be 
explained by a  reversible association of spectrin with the 
muscle membrane. The AChR in spectrin-poor regions are 
usually more poorly organized and less densely clustered 
than receptors associated with/3-spectrin. This poor organi- 
zation may reflect the dissociation of spectrin during cluster 
isolation, or the possibility that clusters were isolated as they 
were forming or dispersing, stages when the binding of spec- 
trin to the membrane may be more reversible. Changes in the 
extractability of  membrane-bound spectrin occur in differen- 
tiating  epithelial  cells  (55).  Alternatively, the  absence of 
/3-spectrin from some regions of AChR clusters may indicate 
that/3-spectrin is not absolutely required for AChR clus- 
tering. 
Our results show that an isoform of/5-spectrin is associated 
with the nicotinic AChR of cultured rat myotubes, but we be- 
lieve that the association between spectrin and postsynaptic 
receptors may well be more general.  Together with actin, 
spectrin has already been found at synaptic contacts in the 
Mauthner cells of the goldfish (41) and at postsynaptic densi- 
ties in mammalian brain (25,  40, 78).  Spectrin may be in- 
volved in the differentiation of muscle and nerve (44, 45, 53, 
54,  64,  78,  79).  The close association of/3-spectrin with 
clustered AChR,  and the similarities between clusters and 
the developing neuromuscular junction (16), suggest that the 
unusual isoform of/3-spectrin that we have described here 
may play an important role in synaptic morphogenesis. 
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